Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1, and the interferons is blocked by inhibitionof prostaglandin synthesis

Endocrinology

Volumn 130, Issue 1, 1992, Pages 10-16

  Feingold, Kenneth R ^a,e   Doerrler, William ^a   Dinarello, Charles A ^b   Fiers, Walter ^c   Grunfeld, Carl ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GHENT UNIVERSITY   (Belgium)

^d DEPARTMENT OF VETERANS AFFAIRS   (United States)

^e SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CYTOKINE; FATTY ACID; GLYCEROL; INDOMETACIN; INTERLEUKIN 6; PROSTAGLANDIN; RECOMBINANT ALPHA INTERFERON; RECOMBINANT BETA INTERFERON; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 1BETA; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; FATTY ACID BLOOD LEVEL; HYPERLIPIDEMIA; LIPOLYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION;

3T3 CELLS; ADIPOSE TISSUE; ANIMAL; INDOMETHACIN; INTERFERONS; INTERLEUKIN-1; LIPOLYSIS; MICE; PROSTAGLANDIN ANTAGONISTS; PROSTAGLANDINS; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR NECROSIS FACTOR;

EID: 0026529589     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/endo.130.1.1370149     Document Type: Article

References (53)

1. Beisel WR 1975 Metabolic response to infection. Annu Rev Med 26:9-20
2. Kaufmann RL, Matson CG, Beisel WR 1976 Hypertriglyceridemia produced by endotoxin: Role of impaired triglyceride disposal mechanisms. J Infect Dis 133:548-555
3. Rouzer CA, Cerami A 1980 Hypertriglyceridemia associated with Trypanosoma bruceii bruceii infection in rabbits: Relative effect of triglyceride removal. Mol Biochem Parasit 2:31-38
4. Guckian JC 1973 Role of metabolism in pathogenesis of bacteremia due to Dipbcoccus pneumoniae in rabbits. J Infect Dis 127:1-8
5. Wolfe RR, Shaw JHF, Durkot MJ 1985 Effect of sepsis on VLDL kinetics: Responses in basal state and during glucose infusion. Am J Physiol 248: E732-E740
6. Grunfeld C, Feingold KR 1991 The metabolic effects of tumor necrosis factor and other cytokines. Biotherapy 3:143-158
7. Kawakami M, Pekala PH, Lane MD, Cerami A 1982 Lipoprotein lipase suppression in 3T3-L1 by an endotoxin-induced mediator from exudate cells. Proc Natl Acad Aci USA 79:912-916
8. Pekala PH, Kawakami M, Angus CW, Lane MD, Cerami A 1983 Selective inhibition of synthesis of enzynmes for de novo fatty acid biosynthesis by an endotoxin-induced mediator from exudate cells. Proc Natl Acad Aci USA 80:2743-2747
9. Patton JS, Shepard HM, Wilking H, Lewis G, Aggarwal BB, Eessalu TE, Gavin LA, Grunfeld C 1986 Interferons and tumor necrosis factors have similar catabolic effects on 3T3-L1 cells. Proc Natl Acad Sci USA 83:8313-8317
10. Beutler BA, Cerami A 1985 Recombinant interleukin-1 suppresses lipoprotein lipase activity in 3T3-L1 cells. J Immunol 135:3969-3971
11. Price SR, Mizel SB, Pekala PH 1986 Regulation of lipoprotein lipase synthesis and 3T3-L1 adipocyte metabolism by recombinant interleukin-1. Biochim Biophys Acta 889:374-381
12. Feingold KR, Grunfeld C 1987 Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. J Clin Invest 80:184-190
13. Feingold KR, Serio MJ, Adi S, Moser AH, Grunfeld C 1989 Tumor necrosis factor stimulates hepatic lipid synthesis and secretion. Endocrinology 124:2336-2342
14. Chajek-Shaul T, Friedman G, Stein O, Shiloni E, Etienne J, Stein Y 1989 Mechanism of the hyperlipidemia induced by tumor necrosis factor administration to rats. Biochim Biophys Acta 1001:316-324
15. Feingold KR, Soued M, Staprans I, Gavin LA, Donahue ME, Huang BJ, Moser AH, Gulli R, Grunfeld C 1989 The effect of TNF on lipid metabolism in the diabetic rat: Evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF induced hyperlipidemia. J Clin Invest 83:1116-1121
16. Feingold KR, Mounzer S, Serio MK, Moser AH, Dinarello CA, Grunfeld C 1989 Multiple cytokines stimulate hepatic lipid synthesis in vivo. Endocrinology 125:267-274
17. Grunfeld C, Adi S, Soued M, Moser A, Fiers W, Feingold KR 1990 Search for mediators of the lipogenic effects of tumor necrosis factor: Potential role for interleukin 6. Cancer Res 50:4233-4238
18. Grunfeld C, Verdier JA, Neese R, Moser AH, Feingold KR 1988 Mechanisms by which tumor necrosis factor stimulates hepatic fatty acid synthesis. J Lipid Res 29:1327-1335
19. Feingold KR, Adi S, Staprans I, Moser AH, Neese R, Verdier JA, Doerrler W, Grunfeld C 1990 Diet affects the mechanisms by which TNF stimulates hepatic triglyceride production. Am J Physiol 259: E177-E184
20. Starnes Jr HF, Warren RS, Jeevanandem M, Gabrilove JL, Lar- chian W, Oettgen HF, Brennan MF 1988 Tumor necrosis factor and the acute metabolic response to injury in man. J Clin Invest 82:1321-1325
21. Price SR, Olivecrona T, Pekala PH 1986 Regulation of lipoprotein lipase synthesis by recombinant tumor necrosis factor-the primary regulatory role of the hormone in 3T3-L1 adipocytes. Arch Biochem Biophys 251:738-746
22. Kawakami M, Murase T, Ogawa H, Ishibashi S, Mori N, Takaku F, Shibata S 1987 Human recombinant TNF suppresses lipoprotein lipase activity and stimulates lipolysis in 3T3-L1 cells. J Biochem 101:331-338
23. Dinarello CA, Cannon JG, Mier JW, Bernheim HA, LoPreste G, Lynn DL, Love RW, Webb AC, Auron PE, Reuben RC, Rich A, Wolff SM, Potney SD 1986 Multiple biological activities of human recombinant interleukin-1. J Clin Invest 77:1734-1739
24. Pestka S, Maeda S 1982 The human interferons: Their purification and sequence cloning and expression in bacteria and biological properties. In: Yamamura Y, Hayashi H, Honjo T, Kishimoto T, Muramatsu M, Osawa T (eds) Humoral Factors in Host Defense. Academic Press, New York, pp 191-243
25. Guisez Y, Tison B, Vandekerckhove J, Demolder J, Bauw G, Haegeman G, Fiers W, Contreras R 1991 Production and purification of recombinant human interleukin-6 secreted by the yeast Saccharomyces cerevisiae. Eur J Biochem 198:217-222
26. Karlsson FA, Grunfeld C, Kahn CR, Roth J 1979 Regulation of insulin receptors and insulin responsiveness in 3T3-L1 fatty fibroblasts. Endocrinology 104:1383-1391
27. Grunfeld C, Baird K, Van Obberghen E, Kahn CR 1981 Glucocor- ticoid-induced insulin resistance in vitro: Evidence for both receptor and postreceptor defects. Endocrinology 109:1723-1730
28. Miles J, Glasscock R, Aikens J, Gerich J, Haymond M 1988 A microflurometric method for the determination of free fatty acids in plasma. J Lipid Res 24:96-99
29. Chernick SS, Spooner PM, Garrison MM, Scow RO 1986 Effect of epinephrine and other lipolytic agents on intracellular lipolysis and lipoprotein lipase activity in 3T3-L1 adipocytes. J Lipid Res 27:286-294
30. Sun X-M, Hsueh W 1988 Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor. J Clin Invest 81:1328-1331
31. Bussolino F, Camussi G, Baglioni C 1988 Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin-1 alpha. J Biol Chem 263:11856-11861
32. Dinarello CA, Cannon JG, Wolfe SM, Bernheim HS, Beutler B, Cerami A, Figari IS, Palladino Jr MA, O’Connor JV 1986 Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin-1. J Exp Med 163:1433-1450
33. Tashjian Jr AH, Voelkel EF, Lazzaro M, Goad D, Bosma T, Levine L 1987 Tumor necrosis factor-alpha (cachectin) stimulates bone resorption in mouse calvaria via a prostaglandin-mediated mechanism. Endocrinology 120:2029-2036
34. Stashenko P, Dewhirst FE, Peros WJ, Kent RL, Ago JM 1987 Synergistic interactions between interleukin-1, tumor necrosis factor and lymphotoxin in bone resorption. J Immunol 138:1464-1468
35. Kawakami M, Ishibashi S, Ogawa H, Murase T, Takaku F, Shibata S 1986 Cachectin/TNF as well as interleukin-1 induces prostacyclin synthesis in cultured vascular endothelial cells. Biochem Biophys Res Commun 141:482-487
36. Kettelhut IC, Fiers W, Goldberg AL 1987 The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygen- ase inhibitors. Proc Natl Acad Sci USA 84:4273-4277
37. Talmadge JE, Bowersox O, Tribble H, Lee SH, Shepard HM, Liggitt D 1987 Toxicity of tumor necrosis factor is synergistic with gamma-interferon and can be reduced with cyclooxygenase inhibitors. Am J Pathol 128:410-425
38. Okusawa S, Gelfand JA Ikejima T, Connolly RJ, Dinarello CA 1988 Interleukin-1 induces a shock-like state in rabbits: Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest 81:1162-1172
39. Evans DA, Jacobs DO, Revhaug A, Wilmore DW 1989 The effects of tumor necrosis factor and their selective inhibition by ibuprofen. Ann Surg 209:312-321
40. Kohase M, Henriksen-DeStafano D, May LT, Vilcek J, Sehgal PB 1986 Induction of B2-interferon by tumor necrosis factor: A home- ostatic mechanism in the control of cell proliferation. Cell 45:659-666
41. Brouckaert P, Spriggs DR, Demetri G, Kufe DW, Fiers W 1989 Circulating interleukin-6 during continuous infusion of tumor necrosis factor and interferon-gamma. J Exp Med 169:2257-2262
42. Dinarello CA 1989 Interleukin-1 and its biologically related cytokines. Adv Immunol 44:153-205
43. Johnston DG, Albert KGMM 1982 Hormonal control of ketone body metabolism in the normal and diabetic state. Clin Endocrinol Metab 11:329-361
44. Warren RS, Donner DB, Starnes Jr HF, Brennan MF 1987 Modulation of endogenous hormone action by recombinant human tumor necros is factor. Proc Natl Acad Sci USA 84:8619-8622
45. Ulevitch RJ, Johnston AR, Weinstein DB 1979 New function for high density lipoproteins: Their participation in intravascular reactions of bacterial lipopolysaccharides. J Clin Invest 64:1516-1524
46. Ulevitch RJ, Johnston AR, Weinstein DB 1981 New function for high density lipoproteins: Isolation and characterization of a bacterial lipopolysaccharide-high density lipoprotein complex formed in rabbit plasma. J Clin Invest 67:827-837
47. Van Lenten BJ, Fogelman AM, Haberland ME, Edwards PA 1986 The role of lipoproteins and receptor-mediated endocytos is in the transport of bacterial lipopolysaccharide. Proc Natl Acad Sci USA 83:2704-2708
48. Warren HS, Knights CV, Siber GR 1986 Neutralization and lipoprotein binding of lipopolysaccharides in tolerant rabbit serum. J Infect Dis 154:784-791
49. Munford RS, Hall CL, Lipton JM, Dietschy JM 1982 Biological activity, lipoprotein binding behavior and in vivo disposition of extracted and native forms of Salmonella typhimurium lipopolysaccharides. J Clin Invest 70:877-888
50. Harris HW, Grunfeld C, Feingold KR, Rapp JH 1990 Human VLDL and chylomicrons can protect against endotoxin induced death in mice. J Clin Invest 86:696-702
51. Leong JC, Kane JP, Oleszko O, Levy JA 1977 Antigen specific nonimmunoglobulin factor that neutralizes xenotropic virus is asociated with mouse serum lipoproteins. Proc Natl Acad Sci USA 74:276-280
52. Seganti L, Grassi M, Matromarino P, Pana A, Superti F, Orsi N 1983 Activity of human serum lipoproteins on the infectivity of rhabdoviruses. Microbiology 6:91-99
53. Heumer HP, Menzel HJ, Potratz D, Brake B, Falke D, Utermann G, Dierich MP 1988 Herpes simplex virus binds to human serum lipoproteins. Intervirology 29:68-76